Non-alcoholic fatty liver disease
- Page Path
-
- HOME
- TOPICS
- Non-alcoholic fatty liver disease
- Original Article
- Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
- Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
- Clin Mol Hepatol. 2022;28(2):196-206. Published online January 13, 2022
-
View: 1947 Download: 127
- Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
- Wen-Yue Liu, Xiaofang Zhang, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Rafael S. Rios, Kenneth I. Zheng, Hong-Lei Ma, Xiao-Dong Wang, Qiuwei Pan, Robert J. de Knegt, Luca Valenti, Mohsen Ghanbari, Ming-Hua Zheng
- Clin Mol Hepatol. 2022;28(2):183-195. Published online November 28, 2021
-
View: 2024 Download: 157 Citation: 1
- Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
- Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park
- Clin Mol Hepatol. 2022;28(1):105-116. Published online October 15, 2021
-
View: 2864 Download: 133 Citation: 1
- Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
- Hydar El Jamaly, Guy D Eslick, Martin Weltman
- Clin Mol Hepatol. 2022;28(1):52-66. Published online September 17, 2021
-
View: 3224 Download: 152 Citations: 2
- Editorial
- Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
- Ja-Young Kwon
- Clin Mol Hepatol. 2022;28(1):50-51. Published online November 22, 2021
-
View: 1590 Download: 67
- Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
- Seung Mi Lee, Won Kim
- Clin Mol Hepatol. 2022;28(1):47-49. Published online November 30, 2021
-
View: 1615 Download: 70
- Review
- Recent advances in nonalcoholic fatty liver disease metabolomics
- Hwi Young Kim
- Clin Mol Hepatol. 2021;27(4):553-559. Published online June 8, 2021
-
View: 5026 Download: 302 Citations: 5
- Original Article
- Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
- Yi-Wen Ting, Amanda Shen-Yee Kong, Shamsul Mohd Zain, Wah-Kheong Chan, Hwa-Li Tan, Zahurin Mohamed, Yuh-Fen Pung, Rosmawati Mohamed
- Clin Mol Hepatol. 2021;27(3):486-498. Published online February 23, 2021
-
View: 2403 Download: 197 Citations: 4
- Editorial
- An analysis of polygenic risk scores for non-alcoholic fatty liver disease
- Dae Won Jun
- Clin Mol Hepatol. 2021;27(3):446-447. Published online May 21, 2021
-
View: 2145 Download: 111
- Guideline
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
-
View: 9576 Download: 948 Citations: 38
- Original Article
- Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
- Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding
- Clin Mol Hepatol. 2021;27(2):329-345. Published online January 20, 2021
-
View: 3216 Download: 176 Citations: 5
- Review
- From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
- Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
- Clin Mol Hepatol. 2021;27(2):257-269. Published online March 22, 2021
-
View: 3969 Download: 341 Citations: 22
- Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
- Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim
- Clin Mol Hepatol. 2021;27(2):221-235. Published online December 3, 2020
-
View: 4009 Download: 306 Citations: 12
- Original Article
- Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
- Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
- Clin Mol Hepatol. 2021;27(1):110-124. Published online December 3, 2020
-
View: 5020 Download: 334 Citations: 23
- Editorial
- Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
- Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
- Clin Mol Hepatol. 2021;27(1):83-86. Published online December 3, 2020
-
View: 2592 Download: 121
- Review
- Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
- Gwyneth Soon, Aileen Wee
- Clin Mol Hepatol. 2021;27(1):44-57. Published online November 19, 2020
-
View: 8337 Download: 277 Citations: 8
- The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
- Erica Jennison, Christopher D. Byrne
- Clin Mol Hepatol. 2021;27(1):22-43. Published online December 10, 2020
-
View: 5326 Download: 352 Citations: 21
- Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
- Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
- Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
- Clin Mol Hepatol. 2020;26(4):728-735. Published online October 1, 2020
-
View: 3190 Download: 133 Citations: 12
- Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
- Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul
- Clin Mol Hepatol. 2020;26(4):705-714. Published online October 1, 2020
-
View: 2289 Download: 61 Citations: 2
- Letter to the Editor
- Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
- Dimitrios Patoulias, Michael Doumas
- Clin Mol Hepatol. 2020;26(4):582-583. Published online September 25, 2020
-
View: 1902 Download: 59
- Review
- Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
- Silvia Sookoian, Carlos J. Pirola
- Clin Mol Hepatol. 2020;26(4):461-475. Published online September 10, 2020
-
View: 4834 Download: 224 Citations: 19
- Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
- Kyung-Soo Kim, Byung-Wan Lee
- Clin Mol Hepatol. 2020;26(4):430-443. Published online August 14, 2020
-
View: 5481 Download: 357 Citations: 16
- Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
- Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
- Clin Mol Hepatol. 2020;26(4):383-400. Published online July 17, 2020
-
View: 6064 Download: 436 Citations: 26
- Letter to the Editor
- Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Jung Hwan Yu
- Clin Mol Hepatol. 2020;26(2):240-241. Published online March 23, 2020
-
View: 2368 Download: 39
- Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
- Hyuk Soo Eun
- Clin Mol Hepatol. 2020;26(2):236-237. Published online April 7, 2020
-
View: 2082 Download: 43
- Original Article
- Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky
- Clin Mol Hepatol. 2020;26(2):216-226. Published online December 5, 2019
-
View: 4127 Download: 123 Citations: 7
- Editorial
- Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
- Soung Won Jeong
- Clin Mol Hepatol. 2020;26(2):185-186. Published online March 23, 2020
-
View: 2597 Download: 65
- Review
- Application of transient elastography in nonalcoholic fatty liver disease
- Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
- Clin Mol Hepatol. 2020;26(2):128-141. Published online November 8, 2019
-
View: 9290 Download: 479 Citations: 35
- Letter to the Editor
- Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steatohepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists
- Prasit Phowthongkum, Kanya Suphapeetiporn, Vorasuk Shotelersuk
- Clin Mol Hepatol. 2019;25(4):412-416. Published online June 24, 2019
-
View: 3408 Download: 108 Citation: 1
- Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
- Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas
- Clin Mol Hepatol. 2019;25(3):331-332. Published online May 30, 2019
-
View: 2712 Download: 52
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Artificial intelligence in hepatology, Guest editor: Jeong Won Jang, M.D.
- Novel biomarkers for hepatocellular carcinoma, Guest editor: Bo Hyun Kim, M.D.
- Recent update on therapeutics for NAFLD, Guest editor: Won Kim, M.D.
- Interactions between metabolic phenotypes and chronic liver diseases, Guest editor: Dae Won Jun, M.D.
- All about risk models in hepatocellular carcinoma, Guest editor: Ji Hoon Kim, M.D.
First decision
09 Days
Publication after acceptance
07 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2020-2022)
|
|||||||
